Lactonases with oragnophosphatase activity: Structural and evolutionary perspectives

Chemico-Biological Interactions

Volumn 187, Issue 1-3, 2010, Pages 370-372

  Draganov, Dragomir I ^a  

^a WIL RESEARCH LABORATORIES   (United States)

Author keywords

DFPase; Paraxonase; Phosphotriesterase

Indexed keywords

AMIDASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; ARYLESTERASE; ASCORBIC ACID; BACTERIAL ENZYME; CALCIUM ION; COBALT; DIISOPROPYL FLUOROPHOSPHATASE; DYFLOS; GLUCONOLACTONASE; LACTONE DERIVATIVE; LIVER ENZYME; LONG CHAIN FATTY ACID; MAGNESIUM; MANGANESE; N ACYLHOMOSERINE LACTONE; ORGANOPHOSPHATE INSECTICIDE; PARAOXON; PHOSPHOTRIESTERASE; REGUCALCIN; SARIN; SOMAN; ZINC; ARYLDIALKYLPHOSPHATASE; DIISOPROPYL-FLUOROPHOSPHATASE; HYDROLASE;

ARTICLE; BREVUNDIMONAS DIMINUTA; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME SPECIFICITY; ENZYME STABILITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; HYDROLYSIS; LACTONIZATION; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN FUNCTION; VITAMIN METABOLISM; ANIMAL; BACTERIUM; BLOOD; CHEMISTRY; ENZYMOLOGY; GENETICS; LIVER; METABOLISM; REVIEW;

BACTERIA (MICROORGANISMS); BREVUNDIMONAS DIMINUTA; EUKARYOTA;

ANIMALS; ARYLDIALKYLPHOSPHATASE; BACTERIA; EVOLUTION, MOLECULAR; HUMANS; HYDROLASES; LIVER; PHOSPHORIC TRIESTER HYDROLASES;

EID: 77955516506     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.01.039     Document Type: Article

References (32)

1. Mazur A. An enzyme in animal tissues capable of hydrolyzing the phosphorus-fluoride bond of alkyl fluorophosphates. J. Biol. Chem. 1946, 164:271-289.
2. Aldridge W.N. Serum esterases. II. An enzyme hydrolysing diethyl p-nitrophenyl acetate (E600) and its identity with A-esterase of mammalian sera. Biochem. J. 1953, 53:117-124.
3. La Du B.N. Human serum paraoxonase/arylesterase. Genetic Factors Influencing the Metabolism of Foreign Compounds 1992, 51-91. Pergamon Press, New York. W. Kalow (Ed.).
4. Davies H.G., Richter R.J., Keifer M., Broomfield C.A., Sowalla J., Furlong C.E. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 1996, 14:334-336.
5. Billecke S., Draganov D., Counsell R., Stetson P., Watson C., Hsu C., La Du B.N. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab. Dispos. 2000, 28:1335-1342.
6. Kondo Y., Inai Y., Sato Y., Handa S., Kubo S., Shimokado K., Goto S., Nishikimi M., Maruyama N., Ishigami A. Senescence marker protein 30 functions as gluconolactonase in l-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5723-5728.
7. Roodveldt C., Tawfik D.S. Shared promiscuous activities and evolutionary features in various members of the amidohydrolase superfamily. Biochemistry 2005, 44:12728-12736.
8. Afriat L., Roodveldt C., Manco G., Tawfik D.S. The latent promiscuity of newly identified microbial lactonases is linked to a recently diverged phosphotriesterase. Biochemistry 2006, 45:13677-13686.
9. Primo-Parmo S.L., Sorenson R.C., Teiber J., La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996, 33:498-507.
10. Draganov D.I., La Du B.N. Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch. Pharmacol. 2004, 369:78-88.
11. Draganov D.I., Teiber J.F., Speelman A., Osawa Y., Sunahara R., La Du B.N. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J. Lipid Res. 2005, 46:1239-1247.
12. Teiber J.F., Draganov D.I., La Du B.N. Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3. Biochem. Pharmacol. 2003, 66:887-896.
13. Draganov D.I., Teiber J.F. PONs' natural substrates-the key to their physiological roles. The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism 2008, 297-306. Springer, Dordrecht. B. Mackness, M. Mackness, M. Aviram, G. Paragh (Eds.).
14. Draganov D.I., Stetson P.L., Watson C.E., Billecke S.S., La Du B.N. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J. Biol. Chem. 2000, 275:33435-33442.
15. Aharoni A.L., Gaidukov O., Khersonsky S., Gold McQ., Roodveldt C., Tawfik D.S. The 'evolvability' of promiscuous protein functions. Nat. Genet. 2005, 37:73-76.
16. Khersonsky O., Tawfik D.S. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry 2005, 44:6371-6382.
17. Harel M., Aharoni A., Gaidukov L., Brumshtein B., Khersonsky O., Meged R., Dvir H., Ravelli R.B., McCarthy A., Toker L., Silman I., Sussman J.L., Tawfik D.S. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat. Struct. Mol. Biol. 2004, 11:412-419.
18. Khersonsky O., Tawfik D.S. The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases. J. Biol. Chem. 2006, 281:7649-7656.
19. Yeung D.T., Lenz D.E., Cerasoli D.M. Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates. FEBS J. 2005, 272:2225-2230.
20. Otto T.C., Harsch C.K., Yeung D.T., Magliery T.J., Cerasoli D.M., Lenz D.E. Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes. Biochemistry 2009, 48:10416-10422.
21. Draganov D. Paraoxonase 1 (PON1) as a potential catalytic scavenger in the prophylaxis and treatment of organophosphate poisoning. Medical Aspects of Chemical and Biological Terrorism-Chemical Terrorism and Traumatism 2005, 227-246. Publishing House of the Union of Scientist in Bulgaria, Sofia. A. Monov, C. Dishovski (Eds.).
22. Yeung D.T., Lenz D.E., Cerasoli D.M. Human paraoxonase 1: a potential bioscavenger of oraganophosphorus nerve agents. The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism 2008, 151-170. Springer, Dordrecht. B. Mackness, M. Mackness, M. Aviram, G. Paragh (Eds.).
23. Little J.S., Broomfield C.A., Fox-Talbot M.K., Boucher L.J., MacIver B., Lenz D.E. Partial characterization of an enzyme that hydrolyzes sarin, soman, tabun, and diisopropyl phosphorofluoridate (DFP). Biochem. Pharmacol. 1989, 38:23-29.
24. Billecke S.S., Primo-Parmo S.L., Dunlop C.S., Doorn J.A., La Du B.N., Broomfield C.A. Characterization of a soluble mouse liver enzyme capable of hydrolyzing diisopropyl phosphorofluoridate. Chemico-Biol. Interact. 1999, 119-120:251-256.
25. Kondo Y., Ishigami A., Kubo S., Handa S., Gomi K., Hirokawa K., Kajiyama N., Chiba T., Shimokado K., Maruyama N. Senescence marker protein-30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver. FEBS Lett. 2004, 570:57-62.
26. Chen C.-N., Chin K.-H., Wang A.H.-J., Chou S.-H. The first crystal structure of gluconolactonase important in the glucose secondary metabolic pathways. J. Mol. Biol. 2008, 384:604-614.
27. di Targiany, et al., this volume.
28. Raushel F.M., Holden H.M. Phosphotriesterase: an enzyme in search of its natural substrate. Adv. Enzymol. Relat. Areas Mol. Biol. 2000, 74:51-93.
29. Elias M., Dupuy J., Merone L., Mandrich L., Porzio E., Moniot S., Rochu D., Lecomte C., Rossi M., Masson P., Manco G., Chabriere E. Structural basis for natural lactonase and promiscuous phosphotriesterase activities. J. Mol. Biol. 2008, 379:1017-1028.
30. Konaklieva M.I., Plotkin B.J. Lactones: generic inhibitors of enzymes?. Mini Rev. Med. Chem. 2005, 5:73-95.
31. Jawad Z., Paoli M. Novel sequences propel familiar folds. Structure 2002, 10:447-454.
32. Khersonsky O., Roodveldt C., Tawfik D.S. Enzyme promiscuity: evolutionary and mechanistic aspects. Curr. Opin. Chem. Biol. 2006, 10:498-508.